SANTA CLARA, Calif., Agilent Technologies Inc. (NYSE: A) today announced that Dr. Paul B. Watkins, international drug safety expert and director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, has received an Agilent Thought Leader Award in recognition of his ongoing work developing integrated methods to predict drug-induced liver injury (DILI). This […]
Newton, Mass. — Empiriko, an innovative clinical intelligence company, today announced the availability of its Biomimiks™ technology, a game- changing biomimetic platform that mimics the in vivo metabolism mediated by liver enzymes (cytochrome P450) to enable pharmaceutical researchers to conduct rapid and iterative in vitro and ex vivo drug metabolism studies to predict the metabolic […]
OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a new patent related to its licensed ICE COLD-PCR technology. The patent, titled […]
MALVERN, Pa. and CODOLET, France.– Reaction Biology Corporation (“RBC”), a leading contract research organization providing early stage drug discovery services, announced that it has signed an agreement for Cisbio Bioassays, a cutting-edge biotechnology company in the field of products and services for human in vitro diagnostics and pharmaceutical research, to distribute its epigenetic proteins. RBC […]
SAN DIEGO, Calif. – At the annual Society for Laboratory Automation and Screening (SLAS) conference, Hamilton Robotics has introduces the NIMBUS® PCR Workstation, which is a compact and affordable pipetting workstation enabling fast and flexible assay setup for endpoint, real-time, qPCR or multiplex PCR. The workstation is PCR-kit-neutral, has an easy-to-use software wizard and suits […]
BALTIMORE – Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS™. Sapio’s NGS LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through processing and analysis. Sapio has gained extensive expertise over 5+ years of working with prominent NGS labs resulting in the industry’s leading solution for this important […]
ACM Biolabs, a spin-off company from A*STAR’s Institute of Materials Research and Engineering (IMRE), will market novel plastic cell membranes to be used as low-cost, easily maintained drug targets that help shorten the drug discovery process. What usually takes weeks or even months can now be done in a matter of days using these new […]
IntelliCyt Corporation Announces First Reagent System for Multiplexed Screening of Secreted Proteins
Albuquerque, NM — IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced the MultiCyt™ QBeads™ PlexScreen family of reagents. It is the first commercially available product to enable multiplexed analysis of secreted proteins at the pace and price needed for screening and the […]
PARIS — Cellectis (Paris:ALCLS): Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies. Under the joint offering, clients will […]
CARLSBAD, Calif. Life Technologies Corporation today announces the launch of Lipofectamine® 3000, the company’s most efficient and versatile transfection reagent for nucleic acid delivery in the broadest spectrum of cell lines. The product increases efficiency up to 10-fold in difficult-to-transfect cells, which is key for researchers working with more biologically relevant cell models. “Its superior […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
